1419 — Human Health Holdings Balance Sheet
0.000.00%
- HK$322.62m
- HK$17.26m
- HK$644.43m
- 89
- 95
- 26
- 84
Annual balance sheet for Human Health Holdings, fiscal year end - June 30th, HKD millions except per share, conversion factor applied.
| 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — | 
| Source: | ARS | ARS | ARS | ARS | PRESS | 
| Standards: | IFRS | IFRS | IFRS | IFRS | — | 
| Status: | Final | Final | Final | Final | Final | 
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 145 | 270 | 641 | 490 | 440 | 
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 239 | 424 | 104 | 67 | 94 | 
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 416 | 732 | 797 | 614 | 588 | 
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 65.3 | 224 | 222 | 206 | 222 | 
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 612 | 1,159 | 1,263 | 1,056 | 1,072 | 
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 185 | 301 | 349 | 216 | 204 | 
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 202 | 417 | 455 | 290 | 290 | 
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 410 | 742 | 808 | 767 | 782 | 
| Total Liabilities & Shareholders' Equity | 612 | 1,159 | 1,263 | 1,056 | 1,072 | 
| Total Common Shares Outstanding |